Type 1 Diabetes In Children - Advanced Therapeutics (UK) Ltd

Unique Challenges, Groundbreaking Solution

Dealing with Type 1 diabetes in young children presents unique challenges, demanding a comprehensive approach. At Advanced Therapeutics (UK) Ltd, we recognise the complexities faced by parents and caregivers in managing the condition in this age group. Our innovative Dana CamAPS® FX System is licensed for use in children aged 1 and up, and stands as a groundbreaking solution. Utilising Hybrid Closed Loop technology and its learning algorithm, it tailors insulin delivery every 8-12 minutes, seamlessly adapting to the ever-changing needs and often erratic schedules of young children with Type 1 diabetes.

Type 1 Diabetes in Children – A Complex Journey

Type 1 diabetes in children is complex and involves navigating several intricate factors. Limited communication skills, inconsistent eating patterns, rapid growth and development and a lack of understanding of their condition makes managing Type 1 diabetes in children particularly challenging. These hurdles can result in stress and fatigue for parents and, more critically, put the child at a higher risk of severe hypoglycaemia.

The Dana CamAPS® FX system is approved for use in children aged 1 and up in the UK, meaning it has been specifically proven to address the challenges encountered by this age group. At the heart of its capabilities is the learning algorithm, an innovative feature that plays a central role in the system’s functionality. This algorithm constantly evaluates and adapts, making insulin delivery decisions at intervals as brief as every 8-12 minutes. This dynamic response enables the system to seamlessly accommodate the inherently unpredictable nature of a young child’s lifestyle.

Adaptive Technology For Growing Needs

Children aged 1-6 experience rapid growth and development, resulting in fluctuating insulin sensitivity, which is one of the many factors that makes Type 1 diabetes in children so tricky to treat. The Dana CamAPS® FX system’s adaptive technology ensures that insulin dosage aligns with the child’s stage of development. It accommodates variable eating habits and erratic schedules, offering parents a reliable tool to manage their child’s Type 1 diabetes with confidence.

We understand that managing a child’s Type 1 diabetes places a substantial burden on parents. Dana CamAPS® FX aims to alleviate this stress by providing a user-friendly solution. The learning algorithm not only caters to the child’s unique needs but also eases the constant vigilance required, contributing to the overall well-being of both the child and the family.

Empowering Families With Advanced Therapeutics (UK) Ltd

Choosing Advanced Therapeutics (UK) Ltd means opting for a comprehensive and tailored solution for managing Type 1 diabetes in children. Our Dana Diabecare i System, combined with the CamAPS® FX using Hybrid Closed Loop technology, signifies a revolutionary advancement in Type 1 diabetes care. What’s more, it will teach young children that Type 1 diabetes doesn’t need to hold them back and that they, too, can enjoy life to the fullest.

Embrace the future with confidence, assured that your child’s health and well-being are in capable hands. We’re committed to fostering a healthier tomorrow for the youngest generation living with Type 1 diabetes, and rest assured that any additional inquiries about our device are welcomed – please don’t hesitate to get in touch.

Get in Touch